前收市價 | 31.27 |
開市 | 31.43 |
買盤 | 0.00 x 1100 |
賣出價 | 0.00 x 1100 |
今日波幅 | 31.34 - 32.14 |
52 週波幅 | 21.83 - 39.78 |
成交量 | |
平均成交量 | 1,168,380 |
市值 | 3.207B |
Beta 值 (5 年,每月) | 1.55 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.38 |
業績公佈日 | 2023年2月21日 - 2023年2月27日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 45.25 |
Thursday after close, Evolent Health Inc (NYSE: EVH) agreed to acquire Magellan Specialty Health, the specialty benefit management organization owned by Centene Corporation (NYSE: CNC), for $650 million at the close plus additional contingent consideration of up to $150 million based on 2023 performance. William Blair is positive on the acquisition and believes this is consistent with management's prior commentary that Evolent would consider strategic assets that fit under the specialty care man
Evolent Health Inc (NYSE: EVH) has agreed to acquire NIA (also known as Magellan Specialty Health), the specialty benefit management organization owned by Centene Corporation (NYSE: CNC). The organization focuses on managing cost and quality in radiology, musculoskeletal, physical medicine, and genetics. Deal consideration includes $650 million at the close plus additional contingent consideration of up to $150 million based on 2023 performance. The upfront consideration will be partly funded by
In this article, we discuss the top 10 small-cap stocks from Ray Dalio’s Q3 2022 portfolio. If you want to see more stocks in this selection, check out Ray Dalio Stock Portfolio Q3 2022: Top 5 Small-Cap Stocks. According to Royce Investment Partners, although equity prices declined in the volatile market environment through the first […]